Marinus Pharmaceuticals Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Marinus Pharma (MRNS) 5M Common Stock Offering Prices at $6/Share
November 6, 2015 9:15 AM ESTMarinus Pharma (NASDAQ: MRNS) announced the pricing of an underwritten public offering of 5,000,000 shares of common stock for a public offering price of $6.00 per share. The net proceeds to Marinus from this offering are expected to be approximately $27.7 million, after deducting the underwriting discounts and... More
